CRP and atherosclerosis: Although weight loss itself is of potential interest in the atherosclerosis field, it was also shown that rimonabant improved other cardiovascular risk factors, e.g., LDL/high density lipoprotein (HDL) cholesterol ratio, tri-glycerides, and C-reactive protein (CRP).